Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Summary

The purpose of this study is to prove the safety and efficacy of Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution 20% followed by 10 J/cm2 of blue light delivered at 10 mW/cm2 or 20 mW/cm2 in the treatment of multiple actinic keratosis on the face or balding scalp (the Treatment Area), utilizing a 14-18 hour incubation period.

Timeline

Start

2017-03

Primary completion

2017-09

Completion

2018-01

Outcome

Outcome not reported

Stopped (Business): “Study withdrawn due to corporate business decision”

Drugs

Indications